Alagoz, Mehmet AbdullahKarakurt, ArzuHepokur, CeylanSalva, EmineOnkol, TijenGhoneim, Mohammed M.Abdelgawad, Mohamed A.2024-08-042024-08-0420212227-9717https://doi.org/10.3390/pr9112019https://hdl.handle.net/11616/100322In this study, 12 new 1-aryl-2-(3,5-dimethylpyrazol-1-yl)ethanone oxime ether derivatives were designed and synthesized to investigate their cytotoxic effects. The in vitro cytotoxic activities of the compounds were evaluated against cervix, colon, breast, glioma, neuroblastoma, and lung cancer cell lines, as well as a healthy cell line using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-lium bromide (MTT) assays with 5-fluorouracil (5-FU) as the reference compound. Compound 5f (IC50 = 5.13 mu M) was found to be more effective than 5-FU (IC50 = 8.34 mu M) in the C6 cancer cell line, and it had no cytotoxic effect on the L929 healthy cell line. Flow cytometry was used to investigate the mechanism of action of compound 5f on the cell cycle of the C6 cell line. The analysis showed that cell death was significantly due to apoptosis. These results indicate that compound 5f induces cell cycle arrest, and may be effective in treating glioma.eninfo:eu-repo/semantics/openAccess3,5-dimethylpyrazoleoxime ethercytotoxic activitygliomaneuroblastomaArticle91110.3390/pr91120192-s2.0-85119591126Q2WOS:000724218100001Q2